Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 34.81%22.18B | 24.46%5.19B | 0.32%5.53B | 74.44%6.04B | 63.80%5.42B | 12.33%16.45B | -17.47%4.17B | 47.28%5.51B | 4.25%3.46B | 30.66%3.31B |
Cost of revenue | 155.77%5.89B | 30.11%625.26M | 20.79%1.17B | 325.61%2.13B | 455.74%1.96B | 4.69%2.3B | -53.47%480.57M | 91.20%969.01M | 30.31%501.31M | 27.62%353.5M |
Gross profit | 15.11%16.28B | 23.73%4.56B | -4.05%4.36B | 31.92%3.91B | 16.96%3.46B | 13.68%14.15B | -8.21%3.69B | 40.39%4.54B | 0.84%2.96B | 31.04%2.96B |
Operating expense | 11.94%12.62B | 18.21%3.7B | 5.22%3.13B | 11.83%2.93B | 12.21%2.86B | 13.40%11.27B | 10.42%3.13B | 22.02%2.98B | 11.82%2.62B | 9.57%2.55B |
Operating profit | 27.55%3.66B | 54.87%859.37M | -21.73%1.22B | 185.55%978.25M | 46.28%602.31M | 14.79%2.87B | -52.97%554.89M | 96.95%1.56B | -42.40%342.58M | 720.86%411.76M |
Net non-operating interest income (expenses) | 177.17%41.68M | 57.33%13.95M | 943.56%16.22M | 199.01%6.03M | 110.83%5.49M | 14.48%15.04M | 72.22%8.86M | -9.97%1.55M | -57.47%2.02M | 70.91%2.6M |
Non-operating interest income | 103.09%45.99M | 32.86%14.27M | 313.13%16.02M | 108.76%8.25M | 82.75%7.45M | 15.00%22.64M | 59.25%10.74M | 15.45%3.88M | -38.17%3.95M | 27.49%4.08M |
Non-operating interest expense | -43.34%4.31M | -82.87%321K | -108.43%-196K | 14.87%2.23M | 33.13%1.96M | 16.03%7.61M | 17.42%1.87M | 42.31%2.32M | 17.11%1.94M | -12.01%1.47M |
Net investment income | 54.57%33.09M | 147.91%26.45M | 71.31%-26.74M | -83.47%10.75M | -78.40%22.62M | -73.92%21.41M | -200.33%-55.21M | -619.74%-93.19M | 389.96%65.07M | 2,607.95%104.73M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -115.22%-5.56M | -101.99%-838K | -1K | 1,139.72%36.55M | 3,272.96%42.01M | 0 | ||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | 68.79%-7.56M | -166.92%-2.02M | 53.69%-6.1M | 52.90%-7.22M | 516.40%7.78M | -7.97%-24.21M | 162.60%3.02M | -46.40%-13.17M | -128.59%-15.33M | 166.39%1.26M |
Income before tax | 27.53%3.72B | 62.02%896.91M | -17.24%1.21B | 152.80%983.08M | 22.65%638.2M | 13.59%2.92B | -55.14%553.57M | 81.30%1.46B | -35.74%388.88M | 820.72%520.36M |
Income tax | 4.17%830.52M | 150.08%168.3M | -25.38%329.33M | 69.17%185.82M | -17.74%147.06M | -2.17%797.27M | -83.05%67.3M | 88.96%441.34M | -43.28%109.84M | 2,001.14%178.78M |
Net income | 36.31%2.89B | 49.84%728.61M | -13.71%876.88M | 185.72%797.26M | 43.79%491.14M | 20.91%2.12B | -41.89%486.27M | 78.16%1.02B | -32.19%279.04M | 643.95%341.57M |
Net income continuous operations | 36.31%2.89B | 49.84%728.61M | -13.71%876.88M | 185.72%797.26M | 43.79%491.14M | 20.91%2.12B | -41.89%486.27M | 78.16%1.02B | -32.19%279.04M | 643.95%341.57M |
Noncontrolling interests | 271.26%32.33M | 57.20%12.03M | 101.11%7.78M | 1,675.53%15.02M | 31.51%-2.51M | -78.14%8.71M | -61.36%7.65M | -36.86%3.87M | -94.86%846K | -43.21%-3.66M |
Net income attributable to the company | 35.34%2.86B | 49.72%716.58M | -14.15%869.1M | 181.19%782.24M | 42.99%493.65M | 23.21%2.11B | -41.42%478.62M | 79.41%1.01B | -29.58%278.19M | 673.12%345.24M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 35.34%2.86B | 49.72%716.58M | -14.15%869.1M | 181.19%782.24M | 42.99%493.65M | 23.21%2.11B | -41.42%478.62M | 79.41%1.01B | -29.58%278.19M | 673.12%345.24M |
Gross dividend payment | ||||||||||
Basic earnings per share | 35.20%150.18 | 49.58%37.59 | -14.25%45.61 | 180.85%41.06 | 42.89%25.92 | 23.05%111.08 | -41.53%25.13 | 79.21%53.19 | -29.64%14.62 | 672.24%18.14 |
Diluted earnings per share | 35.15%150.12 | 49.54%37.58 | -14.31%45.58 | 180.78%41.05 | 42.83%25.91 | 23.05%111.08 | -41.49%25.13 | 79.21%53.19 | -29.64%14.62 | 672.24%18.14 |
Dividend per share | 35.71%76 | 30.30%43 | 0 | 43.48%33 | 0 | 21.74%56 | 17.86%33 | 0 | 27.78%23 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |